EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

Letermovir and Tacrolimus Drug–Drug Interaction in a Pediatric Kidney Transplant Patient: A Case Report and Review of the Literature

Iona Berger iD, Mina Matsuda-Abedini iD, Kathryn Haubrich iD

Pediatric Transplantation · 2025

DOI: 10.1111/petr.70143 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pediatric Transplantation, 2025. Verfasst von Iona Berger und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, BC Children's Hospital, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Tacrolimus, Kidney Transplantation, Antiviral Agents, Immunosuppressive Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cytomegalovirus (CMV) viremia is one of the most common opportunistic infections following solid organ transplant (SOT) in pediatric patients and can be associated with significant morbidity. Valganciclovir is the preferred antiviral medication used for CMV prophylaxis in high‐risk kidney transplant recipients, but its use is limited by myelosuppression. Letermovir is an alternative antiviral medication with lower rates of neutropenia. Letermovir has been implicated in many potential drug–drug interactions, including in combination with tacrolimus.

Methods

This report describes the case of a 6‐year‐old girl, 2 months post‐kidney transplant, at risk for CMV, who received letermovir for CMV prophylaxis after developing neutropenia while receiving valganciclovir. Her maintenance immunosuppression included tacrolimus. This report describes the drug–drug interaction of letermovir and tacrolimus, the dose adjustments required, and summarizes the available literature on the interaction.

Results

While on concurrent letermovir and tacrolimus, the patient required a 36% tacrolimus dose reduction and additional therapeutic drug level monitoring.

Conclusion

This case adds to the current limited data on the interaction of letermovir and tacrolimus in the pediatric SOT population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TacrolimusKidney TransplantationAntiviral AgentsImmunosuppressive AgentsCytomegalovirus InfectionsAcetatesQuinazolinesHumansDrug InteractionsFemaleChild

Stichwörter der Autor:innen

CMVdrug–drug interactionletermovirpediatricprophylaxissolid organ transplantationtacrolimus

Substanzen

TacrolimusletermovirAntiviral AgentsImmunosuppressive AgentsAcetatesQuinazolines

Autor:innen und Institutionen

  • Department of Pharmacy, BC Children's Hospital, Vancouver, British Columbia, Canada.
  • Division of Nephrology, BC Children's Hospital, Vancouver, British Columbia, Canada.
  • Department of Paediatrics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

ORCID-Profile: Iona Berger, Mina Matsuda-Abedini, Kathryn Haubrich

Zitieren

APA

Berger, I., Matsuda-Abedini, M., & Haubrich, K. (2025). Letermovir and Tacrolimus Drug–Drug Interaction in a Pediatric Kidney Transplant Patient: A Case Report and Review of the Literature. Pediatric Transplantation. https://doi.org/10.1111/petr.70143

Vancouver

Berger I, Matsuda-Abedini M, Haubrich K. Letermovir and Tacrolimus Drug–Drug Interaction in a Pediatric Kidney Transplant Patient: A Case Report and Review of the Literature. Pediatric Transplantation. 2025. doi:10.1111/petr.70143

BibTeX
@article{Berger2025,
  author = {Berger, Iona and Matsuda-Abedini, Mina and Haubrich, Kathryn},
  title = {Letermovir and Tacrolimus Drug–Drug Interaction in a Pediatric Kidney Transplant Patient: A Case Report and Review of the Literature},
  journal = {Pediatric Transplantation},
  year = {2025},
  doi = {10.1111/petr.70143}
}
Kostenlos starten →